VEGFA and glioblastoma: In our effort to understand the molecular basis of resistance to anti-VEGF therapy in glioblastoma, we analyzed the gene expression data in xenografts from anti-VEGF-resistant GBM, using bioinformatics tools, and the results suggested that the cells adapt to such conditions by changing gene expression and restoring angiogenesis.